We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 4,208 results
  1. Prostate volume analysis in image registration for prostate cancer care: a verification study

    Combined magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) may enhance diagnosis, aid surgical planning...

    Jessica M. Bugeja, Georges Mehawed, ... Rebecca Murray in Physical and Engineering Sciences in Medicine
    Article Open access 11 October 2023
  2. MRI, CT, and PETSCAN: Engineer’s Perspective

    We first discuss historical developments in tomographic imaging used for medical diagnosis. To discuss magnetic resonance imaging, we introduce the...
    Subhankar Ghosh, Saurabh Pal in Cancer Diagnostics and Therapeutics
    Chapter 2022
  3. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy

    Background

    The proposed trial is to examine the feasibility of prostate-specific membrane antigen (PSMA) positron emission tomography/computed...

    Beihe Wang, Jian Pan, ... Yao Zhu in BMC Cancer
    Article Open access 25 May 2024
  4. False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology

    Background

    The identification of factors responsible for false negative (FN) rate at 18 F- Fluorodeoxyglucose (FDG) Positron Emission Tomography...

    Sebastien Gouy, Veronika Seebacher, ... Désirée Deandreis in BMC Cancer
    Article Open access 06 February 2021
  5. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer

    Background

    The aim of this study was to assess the diagnostic utility of metabolic parameters on fluorine-18-fluoro-2-deoxy-D-glucose-positron...

    Keita Nakanishi, Shota Nakamura, ... Toyofumi Fengshi Chen-Yoshikawa in BMC Cancer
    Article Open access 02 September 2021
  6. Imaging Techniques in Pharmacological Precision Medicine

    Biomedical imaging is a powerful tool for medical diagnostics and personalized medicines. Examples of commonly used imaging modalities include...
    Lucas Freidel, Sixing Li, ... André F. Martins in Precision Medicine
    Chapter 2023
  7. Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial

    Background

    99m Tc radiolabeled nanobody NM-02 ( 99m Tc-NM-02) is a novel single photon emission computed tomography (SPECT) probe with a high affinity...

    Lingzhou Zhao, Yan **ng, ... **hua Zhao in Breast Cancer Research
    Article Open access 08 March 2024
  8. Quantitative Ultrasound: An Emerging Technology for Detecting, Diagnosing, Imaging, Evaluating, and Monitoring Disease

    Ultrasound has been a popular clinical imaging modality for decades. It is a well-established means of displaying the macroscopic anatomy of...
    Chapter 2023
  9. BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer

    Purpose

    The purpose of the study was to evaluate the expression and function of basic leucine zipper ATF-like transcription factor ( BATF) in...

    **a Lu, Jun Liu, ... Mingyu Zhang in Journal of Translational Medicine
    Article Open access 11 June 2024
  10. Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis

    Background

    Renal cell carcinoma (RCC) is one of the most common malignancies worldwide. Noninvasive imaging techniques, such as magnetic resonance...

    Qihua Yin, Huiting Xu, ... Shudong Hu in BMC Cancer
    Article Open access 11 February 2022
  11. PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial

    Background

    Positron emission tomography targeting the prostate specific membrane antigen (PSMA PET/CT) has demonstrated unparalleled performance as a...

    Cynthia Ménard, Sympascho Young, ... Glenn Bauman in BMC Cancer
    Article Open access 08 March 2022
  12. Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis

    Both cancer and fibrosis are diseases involving dysregulation of cell signaling pathways resulting in an altered cellular microenvironment which...

    Alireza Baniasadi, Jeeban P. Das, ... Kathleen M. Capaccione in Journal of Translational Medicine
    Article Open access 13 June 2024
  13. [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial

    Primary aldosteronism (PA) due to a unilateral aldosterone-producing adenoma is a common cause of hypertension. This can be cured, or greatly...

    **lin Wu, Russell Senanayake, ... Morris J. Brown in Nature Medicine
    Article Open access 16 January 2023
  14. Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

    Background

    The study investigated the predictive value of tumor angiogenesis observed by 18 F-ALF-NOTA-PRGD2 II (denoted as 18 F-Alfatide II) positron...

    Yuchun Wei, Xueting Qin, ... Shuanghu Yuan in Journal of Translational Medicine
    Article Open access 02 February 2022
  15. Imaging the Hypoxic Tumor Microenvironment in Cancer Models

    In hypoxic condition oxygen supply is disrupted, and it happens in myocardial infarction, stroke, or tumorous growth. If cells in normal tissue lose...
    Arpana Parihar, Palak Sharma, ... Raju Khan in Hypoxia in Cancer: Significance and Impact on Cancer Therapy
    Chapter 2023
  16. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT

    Purpose

    Stereotactic body radiotherapy (SBRT) is increasingly used for treatment of liver tumors but the effect on metabolic liver function in...

    Michael Sørensen, Mette Marie Fode, ... Morten Høyer in Radiation Oncology
    Article Open access 01 October 2021
  17. Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging

    Background

    18 F-fluciclovine is a synthetic amino acid positron emission tomography (PET) radiotracer that is approved for use in prostate cancer. In...

    N. P. Scott, E. J. Teoh, ... D. R. McGowan in British Journal of Cancer
    Article Open access 18 November 2021
  18. eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma

    Background

    Although eukaryotic initiation factor 6 (eIF6) is a novel therapeutic target, data on its importance in the development of esophageal...

    Yan Gao, Lingling Yuan, ... Zhijun Pei in Journal of Translational Medicine
    Article Open access 06 July 2022
  19. Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative 18F-FDG PET-CT in breast cancer: a retrospective cross-sectional study

    Background

    This study aimed to evaluate the potential of metabolic activity of the psoas muscle measured by 18 F-fluorodeoxyglucose positron emission...

    Keunyoung Kim, In-Joo Kim, ... Hyojeong Kim in BMC Cancer
    Article Open access 27 October 2021
Did you find what you were looking for? Share feedback.